Avidity Partners Management’s Travere Therapeutics TVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-827,010	Closed	-$7.43M	–	98
2023 Q4	$7.43M	Sell	827,010 -495,990	-37%	-$4.46M	0.27%	61
2023 Q3	$11.8M	Buy	+1,323,000	New	+$11.8M	0.48%	62
2020 Q3	–	Sell	-250,000	Closed	-$5.1M	–	85
2020 Q2	$5.1M	Buy	+250,000	New	+$5.1M	0.33%	52